Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02960308 · ClinicalTrials.gov registry record

Whole-Neck Computed Tomography Perfusion Scan in Imaging Patients With Head and Neck Tumors

A clinical trial, sponsored by University of Southern California.

Completed
Registry status
49
Enrollment target

NCT02960308: Completed study, sponsored by University of Southern California.

NCT02960308 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 49 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02960308 has completed, sponsored by University of Southern California.

COMPLETED
Registry status
49 participants
Enrollment target

Study Summary

This pilot clinical trial studies how well whole-neck computed tomography perfusion scans work in imaging patients with head and neck tumors. Diagnostic imaging procedures, such as whole-neck computed tomography perfusions scans, may provide more information about the blood supply to head and neck tumors which may help doctors plan better treatment.

Primary Outcome

Will be compared to traditional neck CTP. Within each patient, the number and sites of each suspicious lymph node will be recorded for the whole-neck imaging area. A 95% confidence interval for the proportion of patients whose status (lymph node negative \[LN-\] versus lymph node positive \[LN+\]) was changed based on the WNCTP image compared to standard of care will be constructed.

Interventions

  • RADIATION Computed Tomography Perfusion Imaging

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2016-10-20
Est. Completion 2021-06-14
University of Southern California

617 total trials

What the finished NCT02960308 record still lists

NCT02960308 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 49 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Computed Tomography Perfusion Imaging is the first listed.

NCT02960308 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02960308 about?

NCT02960308 is a clinical study titled "Whole-Neck Computed Tomography Perfusion Scan in Imaging Patients With Head and Neck Tumors". This pilot clinical trial studies how well whole-neck computed tomography perfusion scans work in imaging patients with head and neck tumors. Diagnostic imaging procedures, such as whole-neck computed tomography perfusions scans, may provide more information about the blood supply to head and neck t...

What is the current status of trial NCT02960308?

This trial is currently completed. The enrollment target is 49 participants. The study started on 2016-10-20. Estimated completion is 2021-06-14.

What interventions are being tested in trial NCT02960308?

The interventions under investigation include: Computed Tomography Perfusion Imaging (RADIATION).

Who is sponsoring clinical trial NCT02960308?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02704858 · 49 participants · Phase 1

    Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma

  • NCT03516708 · 49 participants · Phase 1

    Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer

  • NCT03692429 · 49 participants · Phase 1

    alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells

  • NCT04329494 · 49 participants · Phase 1

    PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02960308, the US trial registry maintained by the National Library of Medicine. NCT02960308 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.